ArticleProceedings of the National Academy of Sciences of the United States of America2018

Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria.

Patrick Strangward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.